Through the combined efforts of our management team and partners, Buffalo BioSciences has rapidly formed, recruited and accelerated the growth and development of several portfolio companies:
Empire Genomics, LLC is a new firm in the field of genetic molecular diagnostics built on the strength of Dr. Norma Nowak’s leading research at Roswell Park Cancer Institute. It offers an extensive range of best in class products and services on its array-based comparative genomics platform technology. The firm services the global genetic research and molecular diagnostic markets and is excited to leverage its technology to help marshal in the exciting new era of personalized medicine.
Sanaan is a healthcare data analytics solutions provider with a goal to end chronic health disparities among socio-ethnic-economically challenged populations using advanced data insights for population health management. Ending health disparities in these populations will help improve the livelihoods of people, improve the economic environment, and create opportunities for communities to thrive. In the value based care (VBC) environment population and risk management mandate that providers and others maximize the opportunities to improve the health of their patients. Sanaan provides tools that better practice management, lower cost of services and increased quality of patient populations. We do this at scale. Sanaan is a New York State minority owned and operated company.